apalutamide will reduce the extent or result of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with prescription drugs that happen to be CYP3A4 substrates can lead to decrease publi